Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 7, 2007 - Issue 5
Submit an article Journal homepage
118
Views
25
CrossRef citations to date
0
Altmetric
Review

Novel inhibitors in the treatment of metastatic melanoma

Kevin Kalinsky Tufts–New England Medical Center, Cancer Center & the Division of Hematology/Oncology, 750 Washington Street, Box 6626, Boston, MA 02111, USA. [email protected]
&
Frank G Haluska Tufts–New England Medical Center, Cancer Center & the Division of Hematology/Oncology, 750 Washington Street, Box 6626, Boston, MA 02111, USA. [email protected]
Pages 715-724 | Published online: 10 Jan 2014

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luigi Strizzi, Lynne-Marie Postovit, Naira V Margaryan, Alina Lipavsky, Jules Gadiot, Christian Blank, Richard EB Seftor, Elisabeth A Seftor & Mary JC Hendrix. (2009) Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Review of Dermatology 4:1, pages 67-78.
Read now
Luigi Pasini, Margherita Y Turco, Lucilla Luzi, Ewa Aladowicz, Ernesta Fagiani & Luisa Lanfrancone. (2009) Melanoma: targeting signaling pathways and RaLP. Expert Opinion on Therapeutic Targets 13:1, pages 93-104.
Read now

Articles from other publishers (23)

Amena Ali & Abuzer Ali. (2021) Integrated computational approaches on pyrazoline derivatives as B-Raf kinase inhibitors for the development of novel anticancer agents. Journal of Molecular Structure 1230, pages 129861.
Crossref
Usama M. Ammar, Mohammed S. Abdel-Maksoud & Chang-Hyun Oh. (2018) Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents. European Journal of Medicinal Chemistry 158, pages 144-166.
Crossref
Hong-Lin Li, Mi-Mi Su, Yun-Jie Xu, Chen Xu, Yu-Shun Yang & Hai-Liang Zhu. (2018) Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition. European Journal of Medicinal Chemistry 155, pages 725-735.
Crossref
Yu-Shun Yang, Bing Yang, Yan Zou, Guigen Li & Hai-Liang Zhu. (2016) Design, biological evaluation and 3D QSAR studies of novel dioxin-containing triaryl pyrazoline derivatives as potential B-Raf inhibitors. Bioorganic & Medicinal Chemistry 24:13, pages 3052-3061.
Crossref
Minmin Yu, Hui Yang, Kaihua Wu, Ying Ji, Lili Ju & Xiaoyuan Lu. (2014) Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma. Bioorganic & Medicinal Chemistry 22:15, pages 4109-4118.
Crossref
Yu-Shun Yang, Fei Zhang, Dan-Jie Tang, Yong-Hua Yang & Hai-Liang Zhu. (2014) Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-Diaryl- 4,5-Dihydro-1H-Pyrazol-5-yl)Phenol Derivatives as Inhibitors of B-Raf Kinase. PLoS ONE 9:5, pages e95702.
Crossref
Hala Bakr El-Nassan. (2014) Recent progress in the identification of BRAF inhibitors as anti-cancer agents. European Journal of Medicinal Chemistry 72, pages 170-205.
Crossref
Bradley J. Newhouse, Steve Wenglowsky, Jonas Grina, Ellen R. Laird, Walter C. Voegtli, Li Ren, Kateri Ahrendt, Alex Buckmelter, Susan L. Gloor, Nathalie Klopfenstein, Joachim Rudolph, Zhaoyang Wen, Xianfeng Li & Bainian Feng. (2013) Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters 23:21, pages 5896-5899.
Crossref
Thomas Jandl, Ekaterina Revskaya, Zewei Jiang, Ruth A Bryan, Arturo Casadevall & Ekaterina Dadachova. (2013) Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma. Immunotherapy 5:4, pages 357-364.
Crossref
Clifton Ming Tay, Chee Wee Ong, Victor Kwan Min Lee & Brendan Pang. (2013) KIT gene mutation analysis in solid tumours: biology, clincial applications and trends in diagnostic reporting. Pathology 45:2, pages 127-137.
Crossref
Thomas Jandl, Ekaterina Revskaya, Zewei Jiang, Matthew Harris, Olena Dorokhova, Dina Tsukrov, Arturo Casadevall & Ekaterina Dadachova. (2013) Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy. Nuclear Medicine and Biology 40:2, pages 177-181.
Crossref
Yu-Shun Yang, Qing-Shan Li, Shuai Sun, Yan-Bin Zhang, Xiao-Liang Wang, Fei Zhang, Jian-Feng Tang & Hai-Liang Zhu. (2012) Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry 20:20, pages 6048-6058.
Crossref
Konstantinos LinosAndrzej Slominski, Jeffrey S RossJ Andrew Carlson. (2011) Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Biomarkers in Medicine 5:3, pages 333-360.
Crossref
Bradley J. Newhouse, Joshua D. Hansen, Jonas Grina, Mike Welch, George Topalov, Nicole Littman, Michele Callejo, Matthew Martinson, Sarah Galbraith, Ellen R. Laird, Barbara J. Brandhuber, Guy Vigers, Tony Morales, Rich Woessner, Nikole Randolph, Joseph Lyssikatos & Alan Olivero. (2011) Non-oxime pyrazole based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3488-3492.
Crossref
Jennifer L. Hunt. 2011. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry 256 290 .
Liliana Ossowski & Julio A. Aguirre-Ghiso. (2010) Dormancy of metastatic melanoma. Pigment Cell & Melanoma Research 23:1, pages 41-56.
Crossref
P. Hersey, L. Bastholt, V. Chiarion-Sileni, G. Cinat, R. Dummer, A.M.M. Eggermont, E. Espinosa, A. Hauschild, I. Quirt, C. Robert & D. Schadendorf. (2009) Small molecules and targeted therapies in distant metastatic disease. Annals of Oncology 20, pages vi35-vi40.
Crossref
J. Andrew Carlson, Jeffrey S. Ross & Andrze J. Slominski. (2009) New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clinics in Dermatology 27:1, pages 75-102.
Crossref
David B. Solit, Iman Osman, David Polsky, Katherine S. Panageas, Adil Daud, James S. Goydos, Jerrold Teitcher, Jedd D. Wolchok, F. Joseph Germino, Susan E. Krown, Daniel Coit, Neal Rosen & Paul B. Chapman. (2008) Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma. Clinical Cancer Research 14:24, pages 8302-8307.
Crossref
A. V. Danilov, O. V. Danilova & B. T. Huber. (2008) Cell cycle control and adhesion signaling pathways in the development of metastatic melanoma. Cancer and Metastasis Reviews 27:4, pages 707-714.
Crossref
Adil I. Daud, Vernon K. Sondak & Ashani Weeraratna. 2008. Melanoma: Translational Research and Emerging Therapies. Melanoma: Translational Research and Emerging Therapies 37 54 .
Marc Moncrieff, Kerwin Shannon, Angela Hong, Peter Hersey & John Thompson. (2008) Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Research 18:2, pages 161-162.
Crossref
. (2008) Current World Literature. Current Opinion in Oncology 20:2, pages 234-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.